Elevated serum levels of FGF-2, NGF and IGF-1 in patients with manic episode of bipolar disorder

Psychiatry Research

Volumn 218, Issue 1-2, 2014, Pages 54-60

  Liu, Xiaohua ^a   Zhang, Tianhong ^a   He, Shen ^a   Hong, Bo ^a   Chen, Zheng ^a   Peng, Daihui ^a   Wu, Yan ^a   Wen, Hui ^a   Lin, Zhiguang ^a   Fang, Yiru ^a   Jiang, Kaida ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Angioneurins; Manic episode of bipolar disorder; Neurotrophic; Serum; Stress

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; NERVE GROWTH FACTOR; SOMATOMEDIN C; VASCULOTROPIN; VASCULOTROPIN A;

ADULT; ARTICLE; BECH RAFAELSEN MANIA RATING SCALE; BIPOLAR DISORDER; BIPOLAR MANIA; CONTROLLED STUDY; DISEASE DURATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PSYCHOLOGICAL RATING SCALE; YOUNG MANIA RATING SCALE; ADOLESCENT; AGED; BLOOD; METABOLISM; MIDDLE AGED; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; BIPOLAR DISORDER; FEMALE; FIBROBLAST GROWTH FACTOR 2; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; NERVE GROWTH FACTOR; VASCULAR ENDOTHELIAL GROWTH FACTOR A; YOUNG ADULT;

EID: 84902086229     PISSN: 01651781     EISSN: 18727123     Source Type: Journal    
DOI: 10.1016/j.psychres.2014.03.042     Document Type: Article

References (53)

1. Abraham J.A., Mergia A., Whang J.L., Tumolo A., Friedman J., Hjerrild K.A., Gospodarowicz D., Fiddes J.C. Nucleotide sequence of a bovine clone encoding the angiogenic protein, basic fibroblast growth factor. Science 1986, 233:545-548.
2. Aloe L., Alleva E., Fiore M. Stress and nerve growth factor: findings in animal models and humans. Pharmacology, Biochemistry, and Behavior 2002, 73:159-166.
3. Aloe L., Bracci-Laudiero L., Bonini S., Manni L. The expanding role of nerve growth factor: from neurotrophic activity to immunologic diseases. Allergy 1997, 52:883-894.
4. Barbosa I.G., Huguet R.B., Neves F.S., Reis H.J., Bauer M.E., Janka Z., Palotas A., Teixeira A.L. Impaired nerve growth factor homeostasis in patients with bipolar disorder. World Journal of Biological Psychiatry: The Official Journal of the World Federation of Societies of Biological Psychiatry 2011, 12:228-232.
5. Beck H., Plate K.H. Angiogenesis after cerebral ischemia. Acta Neuropathologica 2009, 117:481-496.
6. Bendfeldt K., Radojevic V., Kapfhammer J., Nitsch C. Basic fibroblast growth factor modulates density of blood vessels and preserves tight junctions in organotypic cortical cultures of mice: a new in vitro model of the blood-brain barrier. Journal of Neuroscience: The Official Journal of the Society for Neuroscience 2007, 27:3260-3267.
7. Bersani G., Iannitelli A., Fiore M., Angelucci F., Aloe L. Data and hypotheses on the role of nerve growth factor and other neurotrophins in psychiatric disorders. Medical Hypotheses 2000, 55:199-207.
8. Bezchlibnyk Y.B., Xu L., Wang J.F., Young L.T. Decreased expression of insulin-like growth factor binding protein 2 in the prefrontal cortex of subjects with bipolar disorder and its regulation by lithium treatment. Brain Research 2007, 1147:213-217.
9. Blumberg H.P., Wang F., Chepenik L.G., Kalmar J.H., Edmiston E., Duman R.S., Gelernter J. Influence of vascular endothelial growth factor variation on human hippocampus morphology. Biological Psychiatry 2008, 64:901-903.
10. Bullo M., Peeraully M.R., Trayhurn P., Folch J., Salas-Salvado J. Circulating nerve growth factor levels in relation to obesity and the metabolic syndrome in women. European Journal of Endocrinology/European Federation of Endocrine Societies 2007, 157:303-310.
11. Cao L., Jiao X., Zuzga D.S., Liu Y., Fong D.M., Young D., During M.J. VEGF links hippocampal activity with neurogenesis, learning and memory. Nature Genetics 2004, 36:827-835.
12. Carro E., Torres-Aleman I. Serum insulin-like growth factor I in brain function. Keio Journal of Medicine 2006, 55:59-63.
13. Chen G., Manji H.K. The extracellular signal-regulated kinase pathway: an emerging promising target for mood stabilizers. Current Opinion in Psychiatry 2006, 19:313-323.
14. Cheng J.Z., Du J. Mechanical stretch simulates proliferation of venous smooth muscle cells through activation of the insulin-like growth factor-1 receptor. Arteriosclerosis, Thrombosis, and Vascular Biology 2007, 27:1744-1751.
15. Chiu C.T., Wang Z., Hunsberger J.G., Chuang D.M. Therapeutic potential of mood stabilizers lithium and valproic acid: beyond bipolar disorder. Pharmacological Reviews 2013, 65:105-142.
16. Deguchi Y., Naito T., Yuge T., Furukawa A., Yamada S., Pardridge W.M., Kimura R. Blood-brain barrier transport of 125I-labeled basic fibroblast growth factor. Pharmaceutical Research 2000, 17:63-69.
17. Duman R.S., Heninger G.R., Nestler E.J. A molecular and cellular theory of depression. Archives of General Psychiatry 1997, 54:597-606.
18. Einat H., Yuan P., Gould T.D., Li J., Du J., Zhang L., Manji H.K., Chen G. The role of the extracellular signal-regulated kinase signaling pathway in mood modulation. Journal of Neuroscience: The Official Journal of the Society for Neuroscience 2003, 23:7311-7316.
19. Evans S.J., Choudary P.V., Neal C.R., Li J.Z., Vawter M.P., Tomita H., Lopez J.F., Thompson R.C., Meng F., Stead J.D., Walsh D.M., Myers R.M., Bunney W.E., Watson S.J., Jones E.G., Akil H. Dysregulation of the fibroblast growth factor system in major depression. Proceedings of the National Academy of Sciences of the United States of America 2004, 101:15506-15511.
20. Ferrara N., Gerber H.P., LeCouter J. The biology of VEGF and its receptors. Nature Medicine 2003, 9:669-676.
21. Fornaro M., Rocchi G., Escelsior A., Contini P., Ghio M., Colicchio S., De Berardis D., Amore M., Fornaro P., Martino M. VEGF plasma level variations in duloxetine-treated patients with major depression. Journal of Affective Disorders 2013, 151:590-595.
22. Franz B., Buysse D.J., Cherry C.R., Gray N.S., Grochocinski V.J., Frank E., Kupfer D.J. Insulin-like growth factor 1 and growth hormone binding protein in depression: a preliminary communication. Journal of Psychiatric Research 1999, 33:121-127.
23. Gaughran F., Payne J., Sedgwick P.M., Cotter D., Berry M. Hippocampal FGF-2 and FGFR1 mRNA expression in major depression, schizophrenia and bipolar disorder. Brain Research Bulletin 2006, 70:221-227.
24. Hashimoto K., Shimizu E., Iyo M. Critical role of brain-derived neurotrophic factor in mood disorders. Brain research reviews 2004, 45:104-114.
25. Jin K., Zhu Y., Sun Y., Mao X.O., Xie L., Greenberg D.A. Vascular endothelial growth factor (VEGF) stimulates neurogenesis in vitro and in vivo. Proceedings of the National Academy of Sciences of the United States of America 2002, 99:11946-11950.
26. Kapczinski F., Frey B.N., Kauer-Sant'Anna M., Grassi-Oliveira R. Brain-derived neurotrophic factor and neuroplasticity in bipolar disorder. Expert Review of Neurotherapeutics 2008, 8:1101-1113.
27. Kim Y.K., Na K.S., Hwang J.A., Yoon H.K., Lee H.J., Hahn S.W., Lee B.H., Jung H.Y. High insulin-like growth factor-1 in patients with bipolar I disorder: a trait marker?. Journal of Affective Disorders 2013, 151:738-743.
28. Lee B.H., Kim Y.K. Increased plasma VEGF levels in major depressive or manic episodes in patients with mood disorders. Journal of Affective Disorders 2012, 136:181-184.
29. Licht T., Goshen I., Avital A., Kreisel T., Zubedat S., Eavri R., Segal M., Yirmiya R., Keshet E. Reversible modulations of neuronal plasticity by VEGF. Proceedings of the National Academy of Sciences of the United States of America 2011, 108:5081-5086.
30. Magalhaes P.V., Kapczinski F., Nierenberg A.A., Deckersbach T., Weisinger D., Dodd S., Berk M. Illness burden and medical comorbidity in the Systematic Treatment Enhancement Program for Bipolar Disorder. Acta Psychiatrica Scandinavica 2012, 125:303-308.
31. McIntyre R.S., Vagic D., Swartz S.A., Soczynska J.K., Woldeyohannes H.O., Voruganti L.P., Konarski J.Z. Insulin, insulin-like growth factors and incretins: neural homeostatic regulators and treatment opportunities. CNS Drugs 2008, 22:443-453.
32. Molteni R., Fumagalli F., Magnaghi V., Roceri M., Gennarelli M., Racagni G., Melcangi R.C., Riva M.A. Modulation of fibroblast growth factor-2 by stress and corticosteroids: from developmental events to adult brain plasticity. Brain Research Reviews 2001, 37:249-258.
33. Newton S.S., Collier E.F., Hunsberger J., Adams D., Terwilliger R., Selvanayagam E., Duman R.S. Gene profile of electroconvulsive seizures: induction of neurotrophic and angiogenic factors. Journal of Neuroscience: The Official Journal of the Society for Neuroscience 2003, 23:10841-10851.
34. Nowacka M.M., Obuchowicz E. Vascular endothelial growth factor (VEGF) and its role in the central nervous system: a new element in the neurotrophic hypothesis of antidepressant drug action. Neuropeptides 2012, 46:1-10.
35. O'Kusky J.R., Ye P., D'Ercole A.J. Insulin-like growth factor-I promotes neurogenesis and synaptogenesis in the hippocampal dentate gyrus during postnatal development. Journal of Neuroscience: The Official Journal of the Society for Neuroscience 2000, 20:8435-8442.
36. Palomino A., Gonzalez-Pinto A., Martinez-Cengotitabengoa M., Ruiz de Azua S., Alberich S., Mosquera F., Matute C. Relationship between negative symptoms and plasma levels of insulin-like growth factor 1 in first-episode schizophrenia and bipolar disorder patients. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2013, 44C:29-33.
37. Pittenger C., Duman R.S. Stress, depression, and neuroplasticity: a convergence of mechanisms. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 2008, 33:88-109.
38. Quaegebeur A., Lange C., Carmeliet P. The neurovascular link in health and disease: molecular mechanisms and therapeutic implications. Neuron 2011, 71:406-424.
39. Rajkowska G. Postmortem studies in mood disorders indicate altered numbers of neurons and glial cells. Biological Psychiatry 2000, 48:766-777.
40. Reuss B., Dono R., Unsicker K. Functions of fibroblast growth factor (FGF)-2 and FGF-5 in astroglial differentiation and blood-brain barrier permeability: evidence from mouse mutants. Journal of Neuroscience: The Official Journal of the Society for Neuroscience 2003, 23:6404-6412.
41. Reuss B., von Bohlen und Halbach O. Fibroblast growth factors and their receptors in the central nervous system. Cell and Tissue Research 2003, 313:139-157.
42. Riva M.A., Molteni R., Bedogni F., Racagni G., Fumagalli F. Emerging role of the FGF system in psychiatric disorders. Trends in Pharmacological Sciences 2005, 26:228-231.
43. Segi-Nishida E., Warner-Schmidt J.L., Duman R.S. Electroconvulsive seizure and VEGF increase the proliferation of neural stem-like cells in rat hippocampus. Proceedings of the National Academy of Sciences of the United States of America 2008, 105:11352-11357.
44. Segura I., De Smet F., Hohensinner P.J., Ruiz de Almodovar C., Carmeliet P. The neurovascular link in health and disease: an update. Trends in Molecular Medicine 2009, 15:439-451.
45. Sofroniew M.V., Howe C.L., Mobley W.C. Nerve growth factor signaling, neuroprotection, and neural repair. Annual Review of Neuroscience 2001, 24:1217-1281.
46. Sonntag W.E., Ramsey M., Carter C.S. Growth hormone and insulin-like growth factor-1 (IGF-1) and their influence on cognitive aging. Ageing Research Reviews 2005, 4:195-212.
47. Squassina A., Costa M., Congiu D., Manchia M., Angius A., Deiana V., Ardau R., Chillotti C., Severino G., Calza S., Del Zompo M. Insulin-like growth factor 1 (IGF-1) expression is up-regulated in lymphoblastoid cell lines of lithium responsive bipolar disorder patients. Pharmacological Research: The Official Journal of the Italian Pharmacological Society 2013, 73:1-7.
48. Sun F.Y., Guo X. Molecular and cellular mechanisms of neuroprotection by vascular endothelial growth factor. Journal of Neuroscience Research 2005, 79:180-184.
49. Symvoulakis E.K., Vardavas C.I., Fountouli P., Stavroulaki A., Antoniou K.M., Duijker G., Tzatzarakis M.N., Sfiridaki K., Bolonaki E., Alegakis T., Tsatsakis A.M. Time interval from cigarette smoke exposure to blood donation and markers of inflammation: should a smoking cut-off be designated?. Xenobiotica; the Fate of Foreign Compounds in Biological Systems 2010, 40:613-620.
50. Trejo J.L., Piriz J., Llorens-Martin M.V., Fernandez A.M., Bolos M., LeRoith D., Nunez A., Torres-Aleman I. Central actions of liver-derived insulin-like growth factor I underlying its pro-cognitive effects. Molecular Psychiatry 2007, 12:1118-1128.
51. Warner-Schmidt J.L., Duman R.S. VEGF is an essential mediator of the neurogenic and behavioral actions of antidepressants. Proceedings of the National Academy of Sciences of the United States of America 2007, 104:4647-4652.
52. Yang M.J., Tseng J.Y., Chen C.Y., Yeh C.C. Changes in maternal serum insulin-like growth factor-I during pregnancy and its relationship to maternal anthropometry. Journal of the Chinese Medical Association 2013, 76:635-639.
53. Zacchigna S., Lambrechts D., Carmeliet P. Neurovascular signalling defects in neurodegeneration. Nature Reviews. Neuroscience 2008, 9:169-181.